Thomas-Tikhonenko A - Search Results

1

p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers.

Sundaram P, Hultine S, Smith LM, Dews M, Fox JL, Biyashev D, Schelter JM, Huang Q, Cleary MA, Volpert OV, Thomas-Tikhonenko A. Sundaram P, et al. Cancer Res. 2011 Dec 15;71(24):7490-501. doi: 10.1158/0008-5472.CAN-11-1124. Epub 2011 Oct 25. Cancer Res. 2011. PMID: 22028325 Free PMC article.

2

Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies.

Ang Z, Paruzzo L, Hayer KE, Schmidt C, Torres Diz M, Xu F, Zankharia U, Zhang Y, Soldan S, Zheng S, Falkenstein CD, Loftus JP, Yang SY, Asnani M, King Sainos P, Pillai V, Chong E, Li MM, Tasian SK, Barash Y, Lieberman PM, Ruella M, Schuster SJ, Thomas-Tikhonenko A. Ang Z, et al. bioRxiv [Preprint]. 2023 Aug 16:2023.02.19.529123. doi: 10.1101/2023.02.19.529123. bioRxiv. 2023. Update in: Blood. 2023 Nov 16;142(20):1724-1739. doi: 10.1182/blood.2023020400. PMID: 37645778 Free PMC article. Updated. Preprint.

3

An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype.

Ngo CV, Gee M, Akhtar N, Yu D, Volpert O, Auerbach R, Thomas-Tikhonenko A. Ngo CV, et al. Cell Growth Differ. 2000 Apr;11(4):201-10. Cell Growth Differ. 2000. PMID: 10775037 Free PMC article.

4

Whence thrombospondin?

Thomas-Tikhonenko A, Iruela-Arispe ML. Thomas-Tikhonenko A, et al. Cancer Biol Ther. 2004 Apr;3(4):406-7. doi: 10.4161/cbt.3.4.737. Epub 2004 Apr 29. Cancer Biol Ther. 2004. PMID: 15107618 Free article. No abstract available.

5

Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo.

Thomas-Tikhonenko A, Viard-Leveugle I, Dews M, Wehrli P, Sevignani C, Yu D, Ricci S, el-Deiry W, Aronow B, Kaya G, Saurat JH, French LE. Thomas-Tikhonenko A, et al. Cancer Res. 2004 May 1;64(9):3126-36. doi: 10.1158/0008-5472.can-03-1953. Cancer Res. 2004. PMID: 15126350

6

Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity.

Ricci MS, Jin Z, Dews M, Yu D, Thomas-Tikhonenko A, Dicker DT, El-Deiry WS. Ricci MS, et al. Mol Cell Biol. 2004 Oct;24(19):8541-55. doi: 10.1128/MCB.24.19.8541-8555.2004. Mol Cell Biol. 2004. PMID: 15367674 Free PMC article.

7

Targeting beta-transducin repeat-containing protein E3 ubiquitin ligase augments the effects of antitumor drugs on breast cancer cells.

Tang W, Li Y, Yu D, Thomas-Tikhonenko A, Spiegelman VS, Fuchs SY. Tang W, et al. Cancer Res. 2005 Mar 1;65(5):1904-8. doi: 10.1158/0008-5472.CAN-04-2597. Cancer Res. 2005. PMID: 15753389

8

Inactivation of Myc in murine two-hit B lymphomas causes dormancy with elevated levels of interleukin 10 receptor and CD20: implications for adjuvant therapies.

Yu D, Dews M, Park A, Tobias JW, Thomas-Tikhonenko A. Yu D, et al. Cancer Res. 2005 Jun 15;65(12):5454-61. doi: 10.1158/0008-5472.CAN-04-4197. Cancer Res. 2005. PMID: 15958595 Free PMC article.

9

Infection & neoplastic growth 101: the required reading for microbial pathogens aspiring to cause cancer.

Bertout J, Thomas-Tikhonenko A. Bertout J, et al. Cancer Treat Res. 2006;130:167-97. Cancer Treat Res. 2006. PMID: 16610708 Review.

10

Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.

Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, Thomas-Tikhonenko A. Dews M, et al. Nat Genet. 2006 Sep;38(9):1060-5. doi: 10.1038/ng1855. Epub 2006 Jul 30. Nat Genet. 2006. PMID: 16878133 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters